Related by context. All words. (Click for frequent words.) 67 dasatinib Sprycel 65 topical antifungal 65 HCV antiviral 64 sorafenib tablets 63 tumor vascular disrupting 63 IV antihypertensive 62 kidney urologic 62 erlotinib Tarceva ® 62 anaphylaxis eg 62 oral antiviral 62 IAP inhibitor 62 treat chronic sinusitis 62 III antiarrhythmic 62 dasatinib Sprycel ® 62 ophthalmic diseases 61 technologies Obagi Medical 61 Onyx Pharmaceuticals Bayer HealthCare 61 investigational molecular imaging 61 OMNARIS HFA 61 oral anti arrhythmic 61 innovative hemostatic 61 injectable urethral bulking 61 ADP receptor antagonist 61 offer Macroplastique Implants 61 opioid induced constipation OIC 61 fullest DeLaCruz 61 epinephrine corticosteroids intravenous antihistamToskala pads 60 R sorafenib tablets 60 vapreotide acetate 60 receptor tyrosine kinase inhibitor 60 docetaxel Taxotere ® 60 TNF blocking 60 Actemra tocilizumab 60 anti secretory 60 Wafer polifeprosan 60 novel tubulin binding 60 potent triglyceride lowering 60 anti infective treatments 60 candidates Azedra TM 60 PNP inhibitor 60 systemic fungal infections 60 U1 Adaptors 60 forodesine 60 aflibercept VEGF Trap 60 overactive bladder VANTAS R 60 advanced metastatic renal 59 Pazopanib 59 Xyfid TM 59 R DNA demethylating 59 tyrosine kinase inhibitor TKI 59 Ganciclovir 59 Simulect 59 YONDELIS 59 Anti Phospholipid Therapy 59 Tarceva TM 59 vinca alkaloids 59 vinorelbine tartrate 59 atrial fibrillation budiodarone ATI 59 thetreatment 59 pharmacologic stress 59 neuro inflammatory 59 Gleevec imatinib mesylate 59 Nexavar ® 59 Fludara ® 59 investigational antiretroviral 59 refractory Ph + 59 injectable intravascular contrast 59 nucleoside analog 59 lipoglycopeptide 59 acadesine 59 adenosine injection 59 LymphoStat B TM 58 anti inflammatory NSAID 58 inhibits Akt activation 58 either acutely decompensated 58 hemorrhagic fever viruses 58 histone deacetylase HDAC inhibitor 58 Cetrorelix pamoate 58 Cloretazine 58 modulates Akt 58 Citroxin ™ 58 Orphan Drug designations 58 nucleoside analogs 58 novel immunomodulatory 58 oral anticancer 58 hepatitis B HBV 58 cutaneous T 58 Oracea ® 58 fusion enhancers 58 EGFr expressing metastatic colorectal 58 Ixempra 58 ALTROPANE R 58 acetonide FA 58 Sanvar R 58 blood clot dissolving 58 5 HT3 antagonist 58 Vimpat R 58 refractory chronic lymphocytic 58 apoptosis inducer 58 protein kinase inhibitors 58 sorafenib Nexavar 58 Immunotherapeutic 58 TRISENOX ® 58 anti atherothrombotic 58 VISICOL R 58 reslizumab 58 methylnaltrexone bromide 58 psychiatric disorders ATI 58 IMiDs R 58 applying Lipid Sciences 57 Peginterferon alfa 2b 57 sodium stibogluconate 57 MKC# PP 57 systemic antifungal 57 antineoplastic 57 XL# XL# 57 MOVIPREP R 57 anti muscarinic 57 imatinib Gleevec 57 toenail onychomycosis 57 therapeutic radiopharmaceuticals 57 radiolabeled monoclonal antibody 57 lymphoid malignancies 57 IAP inhibitors 57 Dementia Related Psychosis 57 novel emulsion formulation 57 BCR ABL inhibitor 57 ACTIQ ® 57 Anti angiogenic 57 Kristalose ® lactulose 57 adalimumab Humira 57 Cx# [002] 57 Aflibercept 57 alfa 2a 57 Ecallantide 57 Initiates Enrollment 57 Evoltra ® 57 gemtuzumab ozogamicin 57 signal transduction inhibitors 57 ONCASPAR 57 acyclovir Lauriad R 57 SinuNase TM 57 refractory CTCL 57 oropharyngeal candidiasis OPC 57 Romiplostim 57 IMiDs ® 57 microtubule inhibitor 57 MAGE A3 ASCI 57 Apaziquone 57 refractory indolent non 57 Oracea TM 57 oral immunomodulatory 57 Onalta TM 57 novel anticancer 57 anti angiogenic agents 57 MYLOTARG 57 gefitinib Iressa 57 liver resection surgeries 57 oxazolidinone 57 myelodysplastic myeloproliferative diseases 57 EGFR expressing 57 hire Ebonics translators 57 colorectal lung 57 treat enlarged prostate 57 equivocal appendicitis 57 Chemotherapeutic 57 potent antiproliferative 56 post herpetic neuralgia PHN 56 Alferon LDO 56 chronic viral infections 56 LymphoStat B belimumab 56 TELINTRA 56 Combidex 56 myelofibrosis polycythemia vera 56 trastuzumab Herceptin ® 56 Copegus ribavirin 56 opioid induced constipation 56 imatinib Gleevec ® 56 Amgen Neulasta R 56 hepatitis C HCV 56 Merck antihypertensive 56 substrates inhibitors 56 BENLYSTA ® 56 HepaGam B 56 vinca alkaloid 56 Atypical antipsychotic 56 immune modulators 56 Pegloticase 56 inhibits dihydrofolate reductase 56 overactive bladder VANTAS 56 oral ghrelin agonist 56 investigational oral antiplatelet 56 Hsp# Inhibitor 56 PEGylated anti 56 pancreatic NET 56 BCG refractory carcinoma 56 essential thrombocythemia ET 56 TRISENOX R 56 potentially hepatotoxic 56 Genasense ® 56 Clolar ® 56 Orally administered 56 Triapine R 56 LMWHs 56 proteasome inhibitors 56 prokinetic agent 56 thalidomide Thalomid 56 reversing heparin 56 SNT MC# 56 Gamunex C 56 accumulate preferentially 56 Kit CD# positive 56 Lubiprostone 56 lipid modifying 56 AMMONUL R 56 Methylnaltrexone 56 R lenalidomide 56 DepoDur 56 panitumumab Vectibix 56 administered intranasally 56 HYVISC R 56 LHP Nick Hagadone 56 pediatric Crohn disease 56 Derks fainted 56 recurrent glioblastoma multiforme 56 cetuximab Erbitux R 56 taking concomitant nephrotoxic 56 cytoprotective 56 histamine dihydrochloride 56 antiepileptic 56 VALSTAR 56 tubulin inhibitor 56 topical antimicrobial 56 docetaxel Taxotere R 55 oropharyngeal candidiasis 55 overlapping toxicities 55 TradeMark licensed real estate 55 non metastatic osteosarcoma 55 herpetic keratitis 55 immunomodulating 55 aripiprazole Abilify 55 pregabalin Lyrica 55 R bendamustine hydrochloride 55 Behcet uveitis 55 Nonsteroidal anti inflammatory 55 topical non steroidal 55 novel histone deacetylase 55 Proquin XR 55 antibody MAb 55 Nexavar sorafenib 55 anti thrombotic 55 Serostim ® 55 continuous erythropoietin receptor 55 GTC recombinant human 55 Targretin capsules 55 constipation OIC 55 ketolide antibiotic 55 ciprofloxacin hydrochloride 55 potent vascular disrupting 55 antirheumatic 55 interpret wiretapped conversations 55 Neulasta R 55 alkylating agent 55 non nucleoside inhibitor 55 evaluating picoplatin 55 mTOR mammalian target 55 histone deacetylase HDAC inhibitors 55 lenalidomide Revlimid R 55 neuroendocrine cancers 55 defensive linemen Mathias Kiwanuka 55 antimetabolite 55 pegnivacogin 55 albumin bound paclitaxel 55 R rilonacept Injection 55 COLAZAL R 55 polycythemia vera PV 55 metastatic colorectal 55 MTP inhibitor 55 AMEVIVE 55 FDA APPROVES 55 TEMODAL 55 R Saizen R 55 intravenous acetaminophen 55 visit www.celebritycruises.com 55 complementary oligonucleotide active 55 intranasal formulation 55 AVI antisense 55 releasing hormone LHRH 55 Phase #b/#a clinical 55 Cytarabine 55 Civacir 55 Yondelis ® 55 VIVITROL ® 55 histone deacetylase inhibitor 55 Cotara ® 55 CINTREDEKIN BESUDOTOX 55 echinocandins 55 Vitrasert R 55 chemotherapeutic regimen 55 sorafenib Nexavar R 55 Clevudine 55 Achieves Primary Endpoint 55 FUSILEV enhances 55 Hycamtin ® 55 highly purified pasteurized 55 severe gastroparesis 55 small molecule thrombopoietin 55 developing Zerenex ferric 55 Mohammad Azab MD 55 SPRYCEL ® 55 lucinactant 55 Smac mimetic 55 piperacillin tazobactam 55 FOR FURTHER INFORMATION ABOUT 55 Inhalation Solution 54 containing granisetron 54 PEG interferon 54 anti anginal 54 ALN HPN 54 lexidronam injection 54 amrubicin 54 Taiho Pharmaceutical 54 Nexavar prescribing 54 Gel repository corticotropin injection 54 relapsing remitting MS RRMS 54 Velcade bortezomib 54 Cytotoxic 54 inhalation powder 54 proprietary delipidation technologies 54 ® lenalidomide 54 BiovaxID TM 54 anti TNFa 54 nab rapamycin 54 Pafuramidine 54 oral antidiabetic 54 injectable biologic 54 SinuNase ™ 54 Tasimelteon 54 Protease inhibitors 54 painful diabetic neuropathy 54 DORIBAX 54 PGL# 54 complicated intra abdominal 54 Application MAA 54 Recombinant interferon alpha 54 EGFR pathway 54 JAK2 Inhibitor 54 Rituxan rituximab 54 oxymorphone ER 54 tamoxifen Nolvadex ® 54 anti neoplastic 54 FOLOTYN ® 54 IV Busulfex 54 Lenocta TM 54 BYETTA ® 54 Bezielle 54 rheumatoid arthritis psoriatic arthritis 54 peripherally acting 54 Panzem R 54 Liprotamase 54 TYZEKA 54 terlipressin 54 ATG Fresenius S 54 superficial basal cell carcinoma 54 chemotherapy hormonal therapy 54 THALOMID 54 hypereosinophilic syndrome 54 Severe Sepsis 54 psoriasis rheumatoid arthritis 54 RANK Ligand inhibitor 54 subcutaneous formulation 54 GW# [003] 54 Certican 54 ELADUR TM 54 Smac mimetics 54 GABITRIL 54 Phase IIb clinical trials 54 Vidaza R 54 hepatic metastases 54 posaconazole 54 diabetic gastroparesis 54 RhuDex ® 54 PROVIGIL ® 54 rheumatoid arthritis gout 54 Penetrating Therapeutics TM 54 memantine HCl 54 Hodgkin lymphoma HL 54 Rolex Watches Rolex 54 Noxafil 54 AMMONUL R sodium phenylacetate 54 Zorbtive TM 54 situ CIS 54 generation purine nucleoside 54 Kepivance 54 itraconazole Sporanox 54 pegylated interferon alpha 54 Synvisc ONE 54 NUEDEXTA ™ 54 Tibotec Therapeutics division 54 Personalized Immunotherapy 54 indinavir Crixivan 54 posterior uveitis 54 PET molecular imaging 54 Bacillus anthracis anthrax 54 Gleevec Glivec 54 antiresorptive 54 tumor subtypes 54 arthritis PsA 53 oncologic diseases 53 etanercept Enbrel 53 recurrent colorectal cancer 53 mTOR inhibitors 53 anti resorptive 53 invasive candidiasis 53 IV acetaminophen 53 Restanza TM 53 chemotherapeutic agents 53 ergot derivatives 53 multitargeted 53 antimitotic 53 candidate Zelrix 53 magnetic resonance angiography MRA 53 Xolegel 53 Roche Invirase 53 cytotoxics 53 metastatic dermatofibrosarcoma protuberans DFSP 53 negative allosteric modulator 53 Detrol Detrol LA 53 Diabetic Retinopathy DR 53 diarrhea predominant irritable 53 immune modulating 53 endocrine therapies 53 radiation chemoradiation 53 sunitinib Sutent 53 Alkeran 53 call #-#-CARNIVAL 53 mu opioid receptor antagonist 53 anti sickling 53 omega interferon 53 progressive metastatic prostate 53 Hemispherx platform 53 immune suppressive 53 Friedreich Ataxia FRDA 53 molecularly targeted 53 colon carcinomas 53 Receives Orphan Drug Designation 53 induced macular edema 53 antiemetics 53 humanized monoclonal 53 telaprevir VX 53 small molecule chemotherapeutic 53 Hervé Hoppenot President 53 DIFICID ™ 53 Vidaza azacitidine 53 Sabre Vacations 53 diabetic neuropathic pain 53 Diabetic Macular Edema 53 denileukin diftitox 53 refractory cutaneous T 53 ANDA Filing 53 TYGACIL 53 phase III isavuconazole 53 TradeMark licensed 53 Gleevec resistant 53 Orphan Drug status 53 anthrax ricin 53 inhibit angiogenesis 53 call #-#-SAIL-HAL #-#-#-# 53 Soliris eculizumab 53 Deferiprone 53 SYCREST 53 Shows Statistically Significant 53 insulin sensitizing 53 sodium benzoate prescription 53 Chronic Lymphocytic Leukemia CLL 53 Raptiva R 53 overactive bladder syndrome 53 proprietary radiolabeled monoclonal 53 humanized interleukin 6 53 Koresh sect died 53 rufinamide 53 Mike Nicotera Glaus 53 Tygacil 53 hormones stimulants 53 Tiuxetan 53 antiviral antibacterial 53 Xyrem ® 53 Afinitor everolimus 53 endothelin receptor antagonists 53 antiangiogenesis 53 rilonacept 53 Oncaspar 53 albumin naturally occurring 53 Myelodysplastic syndromes 53 investigational antipsychotic 53 injectable antibiotic 53 Remicade infliximab 53 secondary hyperparathyroidism 53 tyrosine kinase inhibitors TKIs 53 Vitrasert ® 53 sublingual tablets 53 cSSTI 53 Bioral Amphotericin B 53 fibrotic disorders 53 STELARA TM 53 Tykerb lapatinib 53 inflammatory autoimmune 53 Amrubicin 53 MGd 53 SUPPRELIN R LA 53 sulfamethoxazole 53 Immunomodulatory 53 metastatic malignant 53 hepatorenal syndrome 53 infliximab Remicade 53 anti mitotic 53 sitagliptin metformin 53 recurrent epithelial ovarian 53 radiotherapeutic 52 microtubule targeting 52 use anticoagulant reversing 52 gluteal injection 52 octreotide acetate 52 Cloretazine R 52 ARIXTRA R 52 GRNOPC1 contains 52 Tasigna nilotinib 52 gastrointestinal stromal 52 IV FENTORA R 52 Enzastaurin 52 factor TNF 52 Irinotecan 52 cognitive impairment associated 52 Pemetrexed 52 Ozarelix 52 neuromuscular blocking 52 Kuvan sapropterin dihydrochloride 52 marketed EGFR 52 Soriatane 52 Raptiva ® 52 multisite environments 52 Saizen ® 52 gadolinium contrast 52 palifermin 52 opioid tolerant adult 52 Onconase 52 Initiate Clinical Trial 52 ALK inhibitors 52 Glioblastoma multiforme GBM 52 mitoxantrone plus 52 R bivalirudin 52 Files IND 52 lintuzumab SGN 52 chronic eosinophilic leukemia 52 HER2 positive cancers 52 miconazole Lauriad ® 52 erythropoietin stimulating agents 52 castrate resistant prostate cancer 52 Octreolin 52 Kamada AAT 52 anticancer treatments 52 stage chemoresistant ovarian 52 autoimmune uveitis 52 Certolizumab pegol 52 Camptosar ® 52 Syndrome LEMS 52 RELISTOR ® 52 visit www.crystalcruises.com 52 DELATESTRYL R 52 oral Janus kinase 52 Sebivo 52 unresectable recurrent 52 k Premarket Notification 52 Somatuline Depot 52 DosePro TM 52 astemizole 52 Aloxi Injection 52 selectively inhibited 52 RAPTIVA 52 miconazole MBT 52 relapsing forms 52 thiazide diuretic 52 untreated de novo 52 Dacogen injection 52 TLR8 agonist 52 DNA demethylating agent 52 taxanes 52 ALN PCS 52 neuro inflammatory disorders 52 CAELYX 52 voriconazole 52 Nicole Onetto MD 52 NMDA antagonists 52 antiparasitic 52 Initiates Clinical Trial 52 Thiovir 52 Opterone R 52 Hexvix ® 52 Cimzia TM 52 antitumoral 52 Taxotere docetaxel 52 metastatic GIST 52 dihydrochloride 52 POSIDUR TM ELADUR TM 52 psoriasis Crohn disease 52 Tigecycline 52 Immunosuppressive 52 MUSE ® 52 HepaGam B TM 52 autologous cellular immunotherapy 52 non resectable 52 hereditary deficiency 52 metastatic HER2 positive 52 Soliris TM eculizumab 52 Inc. NASDAQ SAAS 52 Acute myeloid leukemia 52 Daclizumab 52 arsenic trioxide injection 52 cytolytic 52 Fumbah Sirleaf contacted 52 antiangiogenic agents 52 potent cytotoxic 52 uremic pruritus 52 ACAPODENE R 52 READINGTON NJ An 52 Receives Marketing Authorization 52 Fast Track Status 52 Aviptadil 52 p# MAP kinase inhibitor 52 TNF blocker 52 markets HP Acthar 52 ELIQUIS 52 opioid bowel dysfunction 52 Granted Orphan Drug 52 ORENCIA R 52 basal cell carcinoma squamous 52 Azilect ® 52 irinotecan chemotherapy 52 PKC# 52 Gets FDA Clearance 52 Marketing Authorization Applications 52 metastatic gastric 52 CCR5 mAb 52 BCG refractory 52 loperamide 51 de novo kidney transplant 51 ROYAL-CARI BBEAN 51 basal insulin analogues 51 Mimpara 51 MKC# MT 51 Aloxi ® 51 antidiabetics 51 inhibit EGFR 51 alefacept 51 Immune Globulin Human 51 Cryopyrin Associated Periodic Syndromes 51 Completes Patient Enrollment 51 valopicitabine NM# 51 Intravenous Human 51 PI3K/mTOR 51 HCl capsules 51 narcotics beta blockers 51 relapsed refractory AML 51 REVLIMID R 51 Vidaza ® 51 Scott Boras Ordonez 51 gastrointestinal stromal tumor GIST 51 stage IIIb IV 51 MediGene focuses 51 evaluating tivozanib 51 basiliximab 51 anthracycline containing 51 Retacrit 51 Mylan Receives Approval 51 demethylation agents 51 Parnate 51 Xibrom TM 51 paclitaxel Taxol R 51 Meets Primary Endpoint 51 Martin Nicklasson CEO 51 phosphate binding 51 primary dysmenorrhea 51 Fluconazole 51 psoriasis inflammatory bowel 51 antihypertension 51 sapropterin dihydrochloride 51 renin inhibitors 51 Lambert Eaton Myasthenic 51 hematological disorders 51 metformin hydrochloride 51 beta lactam 51 camptothecin 51 Carbidopa 51 Qfiniti Assist 51 hemorrhagic cystitis 51 aztreonam 51 Advanced Renal Cell 51 cortisol synthesis 51 highly selective endothelin 51 cirrhosis liver failure 51 esophageal candidiasis 51 Remaining Unrestricted Free 51 potent anticancer 51 Mycamine 51 immune modulator 51 topical antibacterial 51 hyaluronidase enzyme 51 advanced nonsquamous non 51 TORISEL 51 rheumatoid arthritis Crohn disease 51 HFA MDI 51 Nivestim 51 Sutent sunitinib 51 PRN FDA Approves 51 Gliadel R 51 Spiegelmer ® 51 anticlotting 51 radioprotective 51 osteoarthritis rheumatoid arthritis 51 Kuvan R 51 anti hyperglycemic 51 Announces Tentative Approval 51 fibrinolytic 51 Angiox ® 51 hormone refractory metastatic prostate 51 Thrombin topical Recombinant 51 anthracyclines taxanes 51 Valproic acid 51 testosterone buccal system 51 VANTAS R 51 beta 1a 51 cromolyn sodium 51 Initiates Clinical 51 Keppra ® levetiracetam 51 diarrhea fatigue asthenia 51 Zavesca ® 51 bladder ovarian 51 Kit Antsey real estate 51 tubulin binding 51 Cetuximab Erbitux 51 IL# PE#QQR 51 gabapentin Neurontin 51 Receives Orphan Drug 51 iodinated contrast 51 VEGF inhibitors 51 Itraconazole 51 injectable collagenase 51 Uvidem 51 Octreotide 51 chronic ITP patients 51 infusional 5-FU/LV 51 cinacalcet HCl 51 Trobalt 51 metastatic bladder 51 ROTATEQ 51 eritoran 51 Campto 51 modafinil Tablets C 51 rasagiline tablets 51 treat opioid induced 51 oral methylnaltrexone 51 REBETOL combination therapy 51 antisense therapies 51 call #-#-SAIL-HAL #-#-# 51 TNF antagonists 51 alkylating 51 cell lymphoma CTCL 51 Berinert 51 Begins Dosing 51 CDPE designated 51 ® tiagabine hydrochloride 51 antihormonal 51 Bleomycin 51 chronic idiopathic thrombocytopenic purpura 51 EVIZON TM 51 efalizumab 51 REMICADE ® 51 Genentech Rituxan 51 KRAS oncogene 51 miconazole Lauriad R 51 benign prostatic hypertrophy BPH 51 Onalta ™ 51 fentanyl buccal tablet 51 patients undergoing percutaneous 51 rheumatoid arthritis inflammatory bowel 51 Initiates Phase II 51 Fixed Dose Combination 51 ABILIFY ® 51 Plaquenil 51 stage IIIB 51 POSIDUR TM 51 cisplatin chemotherapy 50 formerly LymphoStat B 50 Modrenal R 50 oral deforolimus 50 prednisolone sodium phosphate 50 Torisel temsirolimus 50 NanoEmulsion 50 selective modulator 50 glucocorticoid induced osteoporosis 50 Commonly prescribed 50 rheumatoid arthritis osteoarthritis ankylosing 50 inhibit viral replication 50 gastrointestinal radiology 50 glaucoma ischemia 50 ZADAXIN ® 50 Prolongs Survival 50 neutropenia dehydration dyspnea 50 ZALBIN 50 antibody MT# 50 Progressive Multifocal Leukoencephalopathy 50 polycythemia vera essential thrombocythemia 50 pharmacotherapeutic 50 commercializes oncology 50 initiated Phase Ib 50 azacytidine 50 histone deacetylase inhibitors 50 INVEGA ® 50 Stedesa 50 Mycophenolate Mofetil 50 BUPHENYL 50 faropenem medoxomil 50 papillary renal cell carcinoma 50 unresectable liver cancer 50 reteplase 50 immunotherapeutic vaccine 50 diabetic peripheral neuropathic pain 50 OvaRex ® MAb 50 neuro degenerative disorders 50 Troxatyl 50 pemphigus vulgaris 50 Launches Generic Version 50 RELISTOR subcutaneous injection 50 ATryn ® GTC recombinant 50 tiuxetan 50 Severe VOD 50 HDAC Inhibitor 50 fluvoxamine maleate 50 ocular itching associated 50 administered concomitantly 50 Submits Response 50 Evoltra TM 50 refractory acute promyelocytic 50 Azmacort R 50 sildenafil vardenafil tadalafil 50 Vantas 50 Adenoscan 50 Tramiprosate ALZHEMED TM 50 SomatoKine 50 aerosolized KL4 surfactant 50 receiving INTRON 50 ribonucleotide reductase clinically validated 50 lung cancer NSCLC 50 bone marrow suppression 50 leukemia AML 50 urate lowering 50 chronic thromboembolic pulmonary 50 Arimidex anastrozole 50 Staphylococcus infections 50 PEGINTRON TM 50 antifibrinolytic 50 ENTEREG ® 50 Gonal f R 50 URG# targets 50 lamotrigine Lamictal 50 antianginal 50 Cutaneous T 50 Evoltra 50 Faropenem 50 TAXOL R 50 Angiox R 50 synthetic peptide containing 50 Multaq dronedarone 50 EGFR mutation positive 50 LandAmerica serves 50 anti hypertensives 50 Inhalation Aerosol 50 Increlex R 50 eIF 4E 50 Opportunistic infections 50 patientswith 50 Gorlin syndrome 50 oral vancomycin 50 disease CDAD 50 inotropic 50 Orphan Drug Status 50 oxaliplatin Eloxatin 50 Major Depressive Disorder MDD 50 antitumor 50 TORISEL TM 50 Nabi HB Intravenous 50 thalassemia sickle cell 50 photosensitizing 50 EGMI develops sales 50 cardiotoxic 50 fungal bacterial 50 metastatic renal 50 Migranal 50 Successfully Completes Phase 50 haematologic 50 temozolomide TMZ 50 INSPIRE Trial Phase III 50 Savella ® 50 Reports Preclinical Data 50 Anticholinergic 50 cognition enhancing 50 bioscavenger 50 metastatic kidney 50 Her2 positive 50 smallpox anthrax botulism 50 leukemia multiple myeloma 50 erythropoietic 50 Plicera 50 cinacalcet 50 #mg Tablets [002] 50 Ostarine TM 50 immune globulin intravenous 50 Potelligent Technology 50 lidocaine hydrochloride monohydrate powder 50 Inc. OTCBB OXIS 50 Investigational Oral 50 Taxol paclitaxel 50 Angiox 50 rheumatoid arthritis RA psoriatic 50 Orphan Drug designation 50 SANVAR 50 Atypical Hemolytic Uremic Syndrome 50 undergoing coronary angioplasty 50 HERCEPTIN 50 EGFR tyrosine kinase inhibitors 50 Transdrug R 50 Navelbine R 50 FRDA 50 vascular disrupting agents 50 selective inhibition 50 known teratogen substance 50 patients undergoing chemotherapy 50 Vicriviroc 49 thymosin alpha 1 49 antidiabetic 49 Patients Treated With 49 cytostatic 49 reverse transcriptase inhibitors 49 XIAFLEX ® 49 GRALISE 49 combines paclitaxel 49 Zytiga 49 UPLYSO 49 Lamictal ODT 49 ORENCIA ® 49 non splenectomized 49 Alvesco ® 49 concomitantly administered chemotherapy 49 RhuDex TM 49 Abstral ® 49 Gastrointestinal GI 49 Cethromycin 49 ovarian prostate 49 FORADIL 49 pancreatic bladder 49 Anturol TM 49 Temodar ® 49 cisplatin carboplatin 49 Testosterone MDTS ® 49 monoclonal anti 49 Cellegesic 49 soluble tumor necrosis 49 visit carnival.com 49 receptor inhibitors 49 PROVENGE ® 49 ILUVIEN ® 49 dalteparin 49 Phase IIb Trial 49 telomerase activator 49 Torisel 49 Romidepsin 49 immuno modulatory 49 antibacterial antifungal 49 Actimmune ® 49 anticancer antiviral 49 antineoplastic agents 49 Caelyx 49 Brinavess 49 severe hypercholesterolemia 49 prokinetic 49 rhIGF-I/rhIGFBP-3 49 Li Fraumeni Syndrome 49 lymphoma CTCL 49 opioid receptor antagonist 49 Carcinoid tumors 49 rheumatoid arthritis multiple sclerosis 49 antibiotic resistance mechanisms 49 Harleysville distributes 49 Captisol enabled 49 fibrate drugs 49 Stage IIIB IV 49 C1 esterase inhibitor 49 PD LID 49 prostaglandin D2